De Novo ERISA Review Allows Extra-Record Evidence in District Court—But Not Late or on Appeal Absent Scheduling Compliance and “Interests of Justice”

Introduction

In Yu Wang v. Metropolitan Life Insurance Company (11th Cir. July 7, 2026) (unpublished), the Eleventh Circuit affirmed summary judgment for Metropolitan Life Insurance Company (“MetLife”) on an ERISA claim for long-term disability (“LTD”) benefits under a General Electric employee plan. The pro se plaintiff, Yu Wang, alleged disability primarily from symptomatic premature ventricular contractions (“PVCs”) and later argued that anxiety/depression, alone or in combination, also rendered him unable to work.

The appeal presented two central issues: (1) whether MetLife’s benefits denial was wrong even under de novo review; and (2) whether Wang could expand the record on appeal with post-denial medical documents to support a mental-health theory. The court’s most practically important guidance concerns the limits of adding evidence outside the administrative record: de novo review is not a license for “unending continuous review,” and appellate record supplementation remains exceptional.

Summary of the Opinion

  • Standard of review: The panel did not decide whether the Plan clearly conferred discretionary authority (noting Wang “might be right” that it did not), because the district court applied de novo review anyway and the denial was affirmed under that standard.
  • Record supplementation: The court denied Wang’s motion to supplement the appellate record with four post-denial exhibits, emphasizing that such supplementation is rare and that Wang had not properly presented the evidence to the district court.
  • Merits: MetLife’s denial was not “de novo wrong” because objective cardiology testing and the peer review supported the conclusion that Wang’s PVCs were benign and not functionally limiting, and the record lacked evidence of disabling anxiety/depression during the relevant period.
  • Procedural challenges: Wang failed to show a lack of “full and fair review,” and alleged litigation misconduct did not warrant sanctions or relief.

Analysis

Precedents Cited

1) ERISA standard-of-review framework

  • Capone v. Aetna Life Ins. Co., 592 F.3d 1189 (11th Cir. 2010)
    Used for two foundational propositions: (a) appellate review of summary judgment in ERISA cases is de novo, and (b) ERISA does not itself supply a standard of review, so courts apply judge-made standards (de novo vs. arbitrary-and-capricious depending on plan language).
  • Blankenship v. Metropolitan Life Ins. Co., 644 F.3d 1350 (11th Cir. 2011)
    Supplies the Eleventh Circuit’s multi-step framework: first ask whether the denial is “de novo wrong”; if not, affirm without reaching discretion/conflict questions. The panel followed this structure, concluding the denial was not de novo wrong, making further steps unnecessary.
  • Johnson v. Reliance Standard Life Ins. Co., 159 F.4th 1304 (11th Cir. 2025)
    Cited to describe when arbitrary-and-capricious review applies and how it operates (“reasonable basis” suffices even if contrary evidence exists). The opinion used Johnson mainly to frame the dispute about whether plan language expressly conferred discretion.
  • Moon v. Am. Home Assur. Co., 888 F.2d 86 (11th Cir. 1989)
    Critical on the “discretion” question: discretionary authority must be “express,” not implied. This anchored the panel’s observation that Wang “might be right” about the Plan’s lack of express discretion-conferring terms.
  • Kirwan v. Marriott Corp., 10 F.3d 784 (11th Cir. 1994)
    Reinforces that “control and manage” language does not necessarily grant authority to construe plan terms—supporting skepticism about implied discretion.
  • Abatie v. Alta Health & Life Ins. Co., 458 F.3d 955 (9th Cir. 2006) and Ingram v. Martin Marietta Long Term Disability Income Plan, 244 F.3d 1109 (9th Cir. 2001)
    Invoked as persuasive authority: nearly identical language may describe administrative tasks without granting interpretive discretion. The Eleventh Circuit did not adopt a new rule from these cases but used them to illustrate why discretion was debatable.

2) Extra-record evidence, scheduling orders, and limits on appellate supplementation

  • Harris v. Lincoln Nat'l Life Ins. Co., 42 F.4th 1292 (11th Cir. 2022)
    Central to the record issue. Harris held that under de novo review, parties generally may submit evidence beyond the administrative record, including post-denial evidence. But Harris also cautioned (in the footnote quoted here) that de novo review is “not an invitation for unending continuous review” and does not allow parties to ignore scheduling orders governing when the record closes. The panel used this to reject the notion that de novo review automatically permits late-stage additions, especially when not presented to the district court.
  • Shaw v. Conn. Gen. Life Ins., 353 F.3d 1276 (11th Cir. 2003)
    Cited for the general “rule” that de novo review permits extra-record evidence in the district court. The panel paired Shaw with Harris to emphasize the distinction between what de novo review allows in principle and what procedure requires in practice.
  • CSX Transp., Inc. v. City of Garden City, 235 F.3d 1325 (11th Cir. 2000)
    Supplies the strict standard for supplementing the appellate record: the court “rarely” enlarges the record to include material not before the district court, though it has “inherent equitable power” to do so if “in the interests of justice”—especially where the new material would establish “beyond any doubt” the proper resolution. The panel applied this test and concluded Wang’s proffer did not meet it.
  • Jones v. White, 992 F.2d 1548 (11th Cir. 1993)
    Used to reject Wang’s attempt to append an affidavit to his appellate brief without properly requesting supplementation. This reinforces a procedural lesson: even meritorious materials may be disregarded if introduced in the wrong way.

3) Pro se litigation and procedural discipline

  • Campbell v. Air Jam. Ltd., 760 F.3d 1165 (11th Cir. 2014)
    The panel reiterated that pro se filings are liberally construed, but courts cannot act as “de facto counsel” or rewrite deficient filings.
  • Albra v. Advan, Inc., 490 F.3d 826 (11th Cir. 2007)
    Pro se parties must still comply with procedural rules—relevant to the court’s rejection of litigation-misconduct and service-related arguments.
  • Lovett v. Ray, 327 F.3d 1181 (11th Cir. 2003)
    Arguments raised for the first time in a reply brief are not properly before the court.
  • Chudasama v. Mazda Motor Corp., 123 F.3d 1353 (11th Cir. 1997) and Moorer v. Demopolis Waterworks & Sewer Bd., 374 F.3d 994 (11th Cir. 2004)
    Provide the abuse-of-discretion standard for case-management and discovery rulings, under which the district court’s decisions were upheld.

Legal Reasoning

1) The court resolved the appeal at step one: “de novo wrong”

Applying Blankenship, the panel focused on whether the benefits denial was wrong under de novo review. Finding it was not, the court ended the inquiry without needing to decide discretionary authority, conflicts of interest, or arbitrary-and-capricious reasonableness. This approach underscores a practical point: even when discretion is disputed, a claimant can lose if the denial stands on de novo review.

2) Objective support and functional impairment mattered more than labels

On the cardiac theory, the opinion contrasted treating physicians’ work-excuse opinions (Dr. Donohue and Dr. Dua) with objective testing and specialty assessments: Dr. Joy’s workup and Dr. Riley’s electrophysiology review reflected “rare PVCs” and a “relatively benign condition,” and Dr. Riley found PVCs did not explain chest pain. MetLife’s peer reviewer (Dr. Napolitano) documented agreement from Drs. Donohue and Dua that symptoms were more consistent with anxiety than a disabling cardiac impairment. From this, the court drew a functional conclusion: no demonstrated restrictions/limitations preventing performance of occupational duties.

3) Holistic review requires evidence to review

Wang criticized MetLife for not evaluating mental health “holistically” with his cardiac symptoms, but the court treated this as an evidentiary failure: the administrative record contained “stray references” to anxiety/depression/panic-like symptoms without diagnosis, mental-health treatment, or provider-imposed restrictions. When Wang raised mental-health disability in the second appeal, MetLife required documentation of treatment and functional impairment; the court deemed that reasonable under the Plan’s “proof of claim” requirement and the Plan definition of “total disability.”

4) “Full and fair review” arguments failed without concrete omissions

The panel cited ERISA’s “full and fair review” requirement (29 U.S.C. § 1133(2)) and the regulation requiring consideration of claimant submissions (29 C.F.R. § 2560.503-1(h)(2)(iv)). But it rejected Wang’s procedural challenges because: (a) Wang identified October 31, 2022 as the start date; (b) the record showed requests for additional information; (c) Wang did not show relevant, obtainable records were ignored; and (d) MetLife’s denial rationale was consistent rather than shifting.

On independence/impartiality, the court observed that 29 C.F.R. § 2560.503-1(h)(3)(ii) appears to require independence between the initial adverse determination and the appeal, not necessarily independence across multiple levels of appeal. It also emphasized that the second appeal letter was signed by a higher-level employee not involved in the first appeal, undercutting the claim of a meaningless second review.

5) De novo extra-record evidence is mainly a district-court question—timely raised

The opinion reconciles two propositions: (1) under Harris and Shaw, de novo review generally allows evidence beyond the administrative record; but (2) litigants must still comply with scheduling orders, and the appellate court will rarely add evidence never presented to the district court. Wang’s failure to submit the post-denial treatment notes to the district court (despite referencing them) was decisive.

Separately, the court held the proffered exhibits would not “establish beyond any doubt” the correct outcome under CSX Transp., Inc. v. City of Garden City because: an SSA denial did not support Wang; an “educational consultation” lacked diagnosis/treatment; and post-January 2024 treatment said little about disability back to October 2022.

Impact

  • Procedural discipline in de novo ERISA cases: The decision reinforces that while de novo review may allow extra-record evidence, claimants must timely introduce it in the district court and respect case-management deadlines. “De novo” does not mean “evergreen.”
  • Appellate supplementation remains extraordinary: The opinion applies the “interests of justice” / “beyond any doubt” threshold from CSX Transp., Inc. v. City of Garden City in a benefits context, signaling a high barrier to adding medical evidence for the first time on appeal.
  • Mental-health theories require documentation of treatment and functional limits: Especially when first raised late in the administrative process, mental-health disability claims must be supported by diagnosis/treatment records and restrictions/limitations tied to plan definitions.
  • Discretionary-language disputes may not matter if denial survives de novo review: Even where plan language arguably fails the “express discretion” requirement of Moon v. Am. Home Assur. Co., the claimant must still prove disability under the plan.

Complex Concepts Simplified

De novo review
The court decides the benefits question anew—“put itself in the agency’s place” (Harris v. Lincoln Nat'l Life Ins. Co.). In the Eleventh Circuit, this often permits evidence beyond what the administrator reviewed, but only if properly presented in the district court within procedural deadlines.
Arbitrary-and-capricious review
If a plan expressly grants discretion, the administrator wins so long as there is a reasonable basis for the decision (Johnson v. Reliance Standard Life Ins. Co.), with any conflict of interest weighed under Blankenship v. Metropolitan Life Ins. Co.
Administrative record
The set of documents the administrator had when deciding the claim and appeals. Under arbitrary-and-capricious review, courts generally confine review to it. Under de novo review, courts may consider more—subject to scheduling and evidentiary rules.
“Full and fair review”
ERISA requires a meaningful appeal process (29 U.S.C. § 1133(2)), including considering claimant submissions (29 C.F.R. § 2560.503-1(h)(2)(iv)). A claimant still must identify what material was ignored and show it mattered.
“Total disability” (plan-defined)
Not a general medical label; it is a contract definition requiring proof of inability to perform occupational duties (here, “any and every duty” in the first 12 months), supported by evidence of functional restrictions/limitations.

Conclusion

Yu Wang v. Metropolitan Life Insurance Company affirms that ERISA claimants bear the burden to prove plan-defined disability with evidence of functional impairment, and it highlights a crucial procedural boundary: although de novo review may allow extra-record evidence in the district court, parties must timely submit it and follow scheduling orders. Attempts to cure evidentiary gaps by supplementing the record on appeal will usually fail absent a compelling “interests of justice” showing under CSX Transp., Inc. v. City of Garden City.